Spliceosome component TCERG1 regulates the aggressiveness of somatotroph adenoma
Journal of Endocrinological Investigation · 2024
DOI: 10.1007/s40618-024-02447-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endocrinological Investigation, 2024. Verfasst von Kyungwon Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology, Institute of Endocrine Research, Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, S…. Hauptthemen laut MEDLINE: Growth Hormone-Secreting Pituitary Adenoma, Adenoma, Spliceosomes, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: We aimed to identify differentially expressed spliceosome components in growth hormone (GH)-secreting pituitary tumors and investigate their roles in pathogenesis. METHODS: We performed transcriptome analysis of 20 somatotroph adenomas and 6 normal pituitary tissues to select dysregulated spliceosome components. Clinical characteristics were analyzed based on gene expression in 64 patients with acromegaly. Proliferation, invasion, and hormonal activity of GH secreting pituitary adenoma cells were investigated. RESULTS: TCERG1 expression was significantly higher in somatotroph adenomas than in normal pituitaries (log2 fold change 0.59, adjusted P = 0.0002*). Genotype-phenotype analysis revealed that patients with higher TCERG1 expression had lower surgical remission rates than those with lower expression (63.64% vs. 95.45%, P = 0.009*). TCERG1 expression was significantly higher in groups with cavernous sinus (CS) invasion or Ki67 index over 3 (all P>0.05*). TCERG1 overexpression led to a 29.60% increase in proliferation (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology, Institute of Endocrine Research, Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, Republic of Korea.
- Artificial Intelligence and Robotics Laboratory, Myongji Hospital, Goyang, Republic of Korea.
- University of Medicine and Health Sciences, New York, NY, USA.
- Department of Neurosurgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Endocrinology, Institute of Endocrine Research, Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, Republic of Korea. CWK0428@yuhs.ac.
- Endocrinology, Institute of Endocrine Research, Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, Republic of Korea. CR079@yuhs.ac.
ORCID-Profile: Chan Woo Kang, Cheol Ryong Ku
Zitieren
APA
Kim, K., Shin, H. J., Park, S. C., Kim, Y., Lee, M. H., Moon, J. H., Kim, E. H., Lee, E. J., Kang, C. W., & Ku, C. R. (2024). Spliceosome component TCERG1 regulates the aggressiveness of somatotroph adenoma. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-024-02447-7
Vancouver
Kim K, Shin HJ, Park SC, Kim Y, Lee MH, Moon JH, et al. Spliceosome component TCERG1 regulates the aggressiveness of somatotroph adenoma. Journal of Endocrinological Investigation. 2024. doi:10.1007/s40618-024-02447-7
BibTeX
@article{Kim2024,
author = {Kim, Kyungwon and Shin, Hye Ju and Park, Sang-Cheol and Kim, Youngsook and Lee, Min-Ho and Moon, Ju Hyung and Kim, Eui Hyun and Lee, Eun Jig and Kang, Chan Woo and Ku, Cheol Ryong},
title = {Spliceosome component TCERG1 regulates the aggressiveness of somatotroph adenoma},
journal = {Journal of Endocrinological Investigation},
year = {2024},
doi = {10.1007/s40618-024-02447-7}
}
EUVIMED